Virtu Financial LLC bought a new position in Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 6,672 shares of the semiconductor company’s stock, valued at approximately $700,000.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ACLS. Van ECK Associates Corp raised its holdings in shares of Axcelis Technologies by 40.0% in the 3rd quarter. Van ECK Associates Corp now owns 23,751 shares of the semiconductor company’s stock worth $2,490,000 after purchasing an additional 6,786 shares during the period. Royce & Associates LP raised its holdings in Axcelis Technologies by 157.1% in the third quarter. Royce & Associates LP now owns 273,671 shares of the semiconductor company’s stock valued at $28,694,000 after buying an additional 167,235 shares during the period. Harbor Capital Advisors Inc. lifted its position in Axcelis Technologies by 243.8% during the third quarter. Harbor Capital Advisors Inc. now owns 60,328 shares of the semiconductor company’s stock valued at $6,325,000 after buying an additional 42,779 shares in the last quarter. Annex Advisory Services LLC grew its stake in Axcelis Technologies by 72.0% during the third quarter. Annex Advisory Services LLC now owns 12,226 shares of the semiconductor company’s stock worth $1,282,000 after buying an additional 5,118 shares during the period. Finally, FMR LLC grew its stake in Axcelis Technologies by 51.4% during the third quarter. FMR LLC now owns 263,332 shares of the semiconductor company’s stock worth $27,610,000 after buying an additional 89,453 shares during the period. Institutional investors and hedge funds own 89.98% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on ACLS. Needham & Company LLC restated a “hold” rating on shares of Axcelis Technologies in a report on Friday, November 8th. Benchmark cut Axcelis Technologies from a “buy” rating to a “hold” rating in a research note on Friday, November 8th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $167.33.
Axcelis Technologies Stock Performance
Axcelis Technologies stock opened at $75.29 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.45 and a quick ratio of 3.29. The firm’s fifty day moving average price is $84.00 and its 200 day moving average price is $107.34. The company has a market capitalization of $2.45 billion, a price-to-earnings ratio of 11.14, a price-to-earnings-growth ratio of 2.36 and a beta of 1.53. Axcelis Technologies, Inc. has a 12-month low of $69.35 and a 12-month high of $158.61.
Axcelis Technologies Company Profile
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.
Featured Stories
- Five stocks we like better than Axcelis Technologies
- Investing In Preferred Stock vs. Common Stock
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Use the MarketBeat Stock Screener
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.